Goldline Pharmaceutical IPO GMP, Grey Market Premium Today

Goldline Pharmaceutical IPO's GMP is ₹16 on May 11, 2026. If you add this to the IPO price, which is ₹43, you get an estimated listing price of ₹59. This means there's a potential gain of 37.2% per share.The GMP is updated daily, and recently it's been towards the lower side.Keep an eye on daily updates to see how the IPO price is trending.

Check Live IPO GMP List  👈

Upcoming

Last Updated - 11 May, 2026 10:00 am

IPO Price :	43 Rs
IPO GMP :	16  Rs 👈
Expected Listing Price :	43+16 = 59 Rs
Expected IPO Gain %:	37.2% 👈

Lot Shares:	3000
Lot Price:	1,29,000 Rs
Lot Expected Profit:	48,000 Rs

Number Of Lots	Lot Shares	Lot Price	Lot Profit	Lot Expected Listing
1	3000	1,29,000 Rs	48,000 Rs	1,77,000 Rs
2	6000	2,58,000 Rs	96,000 Rs	3,54,000 Rs
3	9000	3,87,000 Rs	1,44,000 Rs	5,31,000 Rs
4	12000	5,16,000 Rs	1,92,000 Rs	7,08,000 Rs
5	15000	6,45,000 Rs	2,40,000 Rs	8,85,000 Rs
6	18000	7,74,000 Rs	2,88,000 Rs	10,62,000 Rs
7	21000	9,03,000 Rs	3,36,000 Rs	12,39,000 Rs
8	24000	10,32,000 Rs	3,84,000 Rs	14,16,000 Rs
9	27000	11,61,000 Rs	4,32,000 Rs	15,93,000 Rs
10	30000	12,90,000 Rs	4,80,000 Rs	17,70,000 Rs
11	33000	14,19,000 Rs	5,28,000 Rs	19,47,000 Rs
12	36000	15,48,000 Rs	5,76,000 Rs	21,24,000 Rs
13	39000	16,77,000 Rs	6,24,000 Rs	23,01,000 Rs

IPO Activity	Date
Open Date:	12 May, 2026
Close Date:	14 May, 2026
Allotment Date:	15 May, 2026
Refund Date:	18 May, 2026
Shares Credit Date:	18 May, 2026
Listing Date:	19 May, 2026

Q.What is Goldline Pharmaceutical IPO GMP Today?

Ans.Goldline Pharmaceutical IPO GMP is ₹16 as of today.

---

Q.What is Goldline Pharmaceutical IPO Expected Returns?

Ans.Goldline Pharmaceutical IPO Expected Returns is 37.2%.